Efficacy and Safety Profile of Lenvatinib and Sorafenib in The Treatment of Adult Patients with Advanced Radioactive-Iodine-Refractory Differentiated Thyroid Cancer (RR-DTC)
Abstract
Authors
P Kawalec
P Kawalec
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now